BioHarvest Sciences Income After Taxes 2020-2024 | BHST

BioHarvest Sciences income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
BioHarvest Sciences Annual Income After Taxes
(Millions of US $)
2023 $-13
2022 $-11
2021 $-10
2020 $-7
2019 $-5
2019 $-5
2018 $-5
BioHarvest Sciences Quarterly Income After Taxes
(Millions of US $)
2024-06-30 $-1
2024-03-31 $-7
2023-12-31 $-7
2023-09-30 $-2
2023-06-30 $-3
2023-03-31 $-1
2022-12-31 $-3
2022-09-30 $-4
2022-06-30 $-2
2022-03-31 $-2
2021-12-31 $-2
2021-09-30 $-3
2021-06-30 $2
2021-03-31 $-7
2020-12-31 $-3
2020-09-30 $-2
2020-06-30 $-1
2020-03-31 $-0
2019-12-31
2019-09-30 $-1
2019-06-30 $-1
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00